# Mannatech Inc

Mannatech Inc is an other based in Coppell, United States.

## Overview

- **Organization type:** other
- **Headquarters:** Coppell, United States
- **Region:** North America
- **Address:** Coppell, Texas, United States
- **Founded:** 1993
- **Assets under management:** Undisclosed
- **Website:** mannatech.com

## Regulatory record

- **Reports private funds:** No

## About

Mannatech Inc was founded in 1993 by Samuel L. Caster and a small group of investors in Coppell, Texas, as a direct-selling health-and-wellness firm. The company went public on the NASDAQ in 1999 (ticker: MTEX). Its core product line centers on Ambrotose, a glyconutrition supplement developed under a proprietary patent portfolio covering plant-derived polysaccharides. The firm's revenue model relies on a global network of hundreds of thousands of independent associates who sell products through in-home parties, online channels, and branded events. Segment mix includes dietary supplements (roughly 80% of revenue), weight-management products, and topical skin-care items. Mannatech manufactures its own products at a facility in Coppell and licenses technology in select markets including Australia, Canada, Japan, Taiwan, and South Africa. Revenue has declined from a peak of roughly $360 million in 2011 to approximately $110 million as of fiscal 2024 (per SEC filings). The company maintains no externally disclosed AUM. It operates without an independent investment office; capital allocation is managed by the CFO and board. In February 2024, Mannatech completed a corporate restructure that reduced its board from nine to five seats, and appointed Al Bala as President and CEO in April 2023 (per SEC filings). Mannatech is structurally distinct from a family office: it is a publicly traded corporation with a direct-selling sales force, not a vehicle for private family wealth. The company does run modest capital — cash and equivalents of roughly $8 million as of fiscal 2024 (per SEC filings) — but is not an allocator of outside capital or a multi-family office.

## Sectors

- Health & Wellness
- Nutrition
- Direct Selling

## People

- Al Bala — President and Chief Executive Officer
- Robert W. Lee — Chief Financial Officer

## Questions

### Who leads investment decisions at Mannatech Inc?

Capital allocation is led by CFO Robert W. Lee, with oversight from the board of directors. The company does not maintain a separate investment team or CIO role.

### What products does Mannatech sell, and how?

The core product is Ambrotose, a glyconutrition supplement. Other lines include weight-management powders, topical skin-care products, and vitamins. Sales occur through a network of independent associates in over 20 countries using a multi-level compensation model.

### Does Mannatech manage capital for outside investors?

No. As a public company, Mannatech does not accept external allocations or manage third-party capital. Its balance sheet is funded through revenue and equity; cash and equivalents as of fiscal 2024 were roughly $8 million (per SEC filings).

### Has Mannatech been involved in regulatory actions?

The firm settled a multi-state investigation in 2007 over health claims for $1.85 million without admitting wrongdoing. In 2010, the SEC fined Mannatech $4 million for accounting irregularities related to revenue recognition (per SEC filings).

## Related profiles

- [Zicix Corp](https://altss.com/profile/zicix-corp)
- [Jupiter Neurosciences, Inc.](https://altss.com/profile/jupiter-neurosciences-inc)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/mannatech-inc

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology